Peptides for Injury Rehabilitation Research

Rehabilitation research investigates peptides that promote tissue-specific healing: BPC-157 for tendon and muscle repair, TB-500 for collagen remodelling and inflammation resolution, and GHK-cu for extracellular matrix restoration. Studies examine wound healing kinetics, inflammatory marker modulation, and functional restoration timelines in injury models.

BPC-157 shows the most robust evidence for accelerated tendon and muscle healing in animal studies, with reduced scarring and improved structural integrity. TB-500 research documents enhanced collagen I/III ratios and systemic inflammation reduction. GHK-cu in vitro studies show collagen synthesis and remodelling activity, though clinical validation remains preliminary.

Most injury rehabilitation studies use animal models or in vitro systems; human clinical trials are limited and often lack proper controls. Recovery timelines in animal models do not directly translate to human athletes. Comparative effectiveness against standard physiotherapy and nutrition is largely unexplored.

No peptides are ARTG-approved for injury rehabilitation. Research-grade peptides can be obtained for institutional study only; clinical use requires specific medical condition registration through TGA. Sports medicine practitioners cannot prescribe peptides for rehabilitation outside approved medical pathways.